MetaCap

CollPlant Biotechnologies Financial Statements

NASDAQ: OPHIHealth CareIndustrial SpecialtiesUSD

3.13-0.08 (-2.49%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CollPlant Biotechnologies revenue and earnings

In fiscal 2025, CollPlant Biotechnologies generated $2.4 million in revenue, up 360.4% from fiscal 2024. CollPlant Biotechnologies reported a net loss of $11.5 million, compared with a loss of $16.6 million a year earlier. Gross margin was 64.8% (up from -215.5%) and operating margin -484.3%.

Diluted earnings per share came in at -$0.94. Over the last 5 fiscal years, OPHI's revenue has grown at a -17.3% compound annual rate (a contraction).

Summary generated from market data by MetaCap's automated system. Methodology

CollPlant Biotechnologies income statement (annual)

CollPlant Biotechnologies annual income statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31FY 20182018-12-31FY 20172017-12-31
Revenue2.37M515.00K10.96M299.00K15.64M6.14M2.32M5.01M463.00K
Revenue growth (YoY)+360.39%-95.30%+3565.22%-98.09%+154.86%+164.75%-53.77%+982.94%—
Cost of Revenue835.00K1.63M1.99M400.00K2.00M3.00M1.88M1.66M48.00K
Gross Profit1.54M-1.11M8.97M-101.00K13.64M3.13M439.00K3.35M415.00K
Operating Expenses13.02M16.14M16.48M17.00M13.57M34.00K3.30M2.18M6.37M
Research & Development8.19M10.52M10.48M10.26M7.63M4.07M4.41M3.88M584.00K
Selling, General & Admin——————3.66M3.72M2.47M
Operating Income-11.48M-17.25M-7.51M-17.10M65.00K-5.60M-7.63M-4.25M-5.96M
Interest Expense——————3.30M2.18M47.00K
Other Income (Expense)-6.00K642.00K493.00K172.00K172.00K-175.00K-3.53M——
Income Tax—45.99M59.99M——————
Net Income-11.49M-16.61M-7.02M-16.93M237.00K-5.77M-11.16M-6.25M-6.05M
Net Income growth (YoY)———-7241.35%—————
EPS (Basic)-0.94-1.45-0.62-1.530.02-0.84-2.231.43—
EPS (Diluted)-0.94-1.45-0.62-1.530.02-0.84-2.231.43—
Shares Outstanding (Basic)12.20M11.45M11.39M11.03M9.97M6.89M4.99M4.38M2.66M
Shares Outstanding (Diluted)12.20M11.45M11.39M11.03M11.97M6.89M4.99M4.38M—
EBITDA-10.57M-16.21M-6.41M-16.02M838.00K-4.94M-7.09M-3.90M-5.73M
Gross Margin64.78%-215.53%81.83%-33.78%87.18%51.08%18.94%66.91%89.63%
Operating Margin-484.31%-3349.71%-68.55%-5718.06%42.00%-91.23%-329.21%-84.66%-1286.61%
Net Margin-484.56%-3225.05%-64.05%-5660.54%1.52%-94.09%-481.62%-124.63%-1306.91%

This table shows 9 annual periods of CollPlant Biotechnologies's income statement, from FY 2025 back to FY 2017, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow OPHI's reporting calendar. What is a income statement?

More financial data